New drugs in the works for muscular dystrophy are showing signs of slowing the disease’s muscle-ravaging impact, raising hopes that patients’ lives may be prolonged for years beyond what current treatments offer. Louis Kunkel, HMS professor of pediatrics at Boston Children’s Hospital, is quoted.
